MFSD12 Knockout HEK293 Cell Line
Cat.No.:
EDC08383
Species:
Human
Cell Name:
HEK293
Gene:
MFSD12
Gene ID:
126321
Size:
1×10⁶cells
MFSD12 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08383 |
|---|---|
| Product Name | MFSD12 Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene | MFSD12 |
| NCBI Gene ID | |
| Gene Synonyms | C19orf28|PP3501|SLC59B1 |
| Summary |
Enables cysteine transmembrane transporter activity. Involved in cysteine transmembrane transport; pigment metabolic process involved in pigmentation; and regulation of melanin biosynthetic process. Located in lysosome and melanosome. Part of late endosome. [provided by Alliance of Genome Resources, Jul 2025]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying MFSD12 function, MFSD12 Knockout HEK293 Cell Line or MFSD12 overexpression HEK293 Cell Line?
The choice depends on whether you are studying MFSD12's role as a lysosomal cysteine/cystine transporter or modeling its association with human skin pigmentation variation. The Knockout line is the standard tool for asking whether MFSD12 is required for these processes — MFSD12 is a lysosomal membrane MFS transporter that imports cysteine and cystine into lysosomes, supplying cysteine for pheomelanin synthesis within melanosomes. Overexpression is useful for studying MFSD12 in heterologous expression contexts.
For pigmentation and lysosomal biology research, the EDITGENE MFSD12 Knockout in HEK293 is a mechanistic platform — HEK293 supports systematic structure-function studies of this MFS family transporter. MFSD12 was identified through GWAS as a major determinant of skin pigmentation variation in African populations — common MFSD12 variants are associated with darker skin pigmentation. MFSD12 loss reduces pheomelanin (the yellow-red pigment) without affecting eumelanin. Rescue with wild-type or transport-deficient MFSD12 enables structure-function studies. This product complements the parallel MFSD12 Knockout in HCT 116 (also available) for biochemistry versus pigmentation-relevant studies.
What are the application scenarios for this model?
Primary applications:
• Lysosomal cysteine/cystine transport: lysosomal cysteine and cystine pool quantification by LC-MS or fluorescent cysteine probes in MFSD12-null cells.
• Pheomelanin synthesis: in heterologous melanocyte-relevant contexts, pheomelanin precursor (cysteinyldopa) and pheomelanin/eumelanin ratio analysis.
• MFSD12 polymorphism studies: rescue with African population MFSD12 variants for pharmacogenomic/pigmentation studies.
• Structure-function studies: rescue with wild-type or transport-deficient MFSD12 in HEK293's high-transfection background.
EDITGENE recommends this HEK293-based model for biochemical MFSD12 research and structure-function studies; the parallel MFSD12 Knockout in HCT 116 (also available) is useful for cross-background validation.
Is this MFSD12 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes. MFSD12 rescue experiments require attention to lysosomal targeting and MFS architecture:
• Construct design: use a codon-modified MFSD12 sequence with a small intracellular tag (FLAG, HA). MFSD12 has 12 transmembrane domains and a lysosomal targeting motif — preserve all elements.
• Lysosomal localization validation: confirm lysosomal membrane localization by LAMP1 co-staining before functional assays.
• Transport-deficient rescue: substrate-binding pocket mutations affecting cysteine/cystine binding abolish transport activity.
• Pigmentation polymorphism rescue: African-population-associated MFSD12 variants (associated with darker skin) enable pigmentation genotype-function studies.
• Functional readout: rescue should restore lysosomal cysteine/cystine pools and pheomelanin synthesis in melanocyte-relevant contexts.
HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.